145 related articles for article (PubMed ID: 8320153)
1. Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms.
Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty M; Powers BE; Henkel SE; Withrow SJ
J Am Vet Med Assoc; 1993 Jun; 202(11):1845-8. PubMed ID: 8320153
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989).
Ogilvie GK; Straw RC; Powers BE; Cooper MF; Withrow SJ
J Am Vet Med Assoc; 1991 Sep; 199(5):613-6. PubMed ID: 1787122
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.
Ogilvie GK; Fettman MJ; Jameson VJ; Walters LM; Lafferty MH; Cooper MF; Powers BE; Ciekot PA; Atwater SW; Withrow SJ
Am J Vet Res; 1992 Sep; 53(9):1666-9. PubMed ID: 1416374
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle of administration.
Forrester SD; Fallin EA; Saunders GK; Kenny JE
Am J Vet Res; 1993 Dec; 54(12):2175-8. PubMed ID: 8116956
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a short-term saline diuresis protocol for the administration of cisplatin.
Ogilvie GK; Krawiec DR; Gelberg HB; Twardock AR; Reschke RW; Richardson BC
Am J Vet Res; 1988 Jul; 49(7):1076-8. PubMed ID: 3421531
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
[TBL] [Abstract][Full Text] [Related]
7. Limb-sparing treatment for osteosarcoma in dogs.
LaRue SM; Withrow SJ; Powers BE; Wrigley RH; Gillette EL; Schwarz PD; Straw RC; Richter SL
J Am Vet Med Assoc; 1989 Dec; 195(12):1734-44. PubMed ID: 2599960
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
[TBL] [Abstract][Full Text] [Related]
9. Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs.
Hardie EM; Page RL; Williams PL; Fischer WD
Am J Vet Res; 1991 Nov; 52(11):1821-5. PubMed ID: 1686160
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cisplatin-induced emesis in dogs with malignant neoplasia: 115 cases (1984-1987).
Ogilvie GK; Moore AS; Curtis CR
J Am Vet Med Assoc; 1989 Nov; 195(10):1399-403. PubMed ID: 2584105
[TBL] [Abstract][Full Text] [Related]
12. Oxytetracycline-induced nephrotoxicosis in dogs after intravenous administration for experimental bone labeling.
Moalli MR; Dysko RC; Rush HG; Chrisp CE; Decoster JL; Sweet KA; Goldstein SA
Lab Anim Sci; 1996 Oct; 46(5):497-502. PubMed ID: 8905581
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary protein conditioning on gentamicin-induced nephrotoxicosis in healthy male dogs.
Grauer GF; Greco DS; Behrend EN; Fettman MJ; Jaenke RS; Allen TA
Am J Vet Res; 1994 Jan; 55(1):90-7. PubMed ID: 7908183
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
18. Experimental citrinin nephrotoxicosis in dogs: renal function evaluation.
Kogika MM; Hagiwara MK; Mirandola RM
Vet Hum Toxicol; 1993 Apr; 35(2):136-40. PubMed ID: 8470356
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
20. Urinary gamma-glutamyl transpeptidase activity in dogs with gentamicin-induced nephrotoxicity.
Greco DS; Turnwald GH; Adams R; Gossett KA; Kearney M; Casey H
Am J Vet Res; 1985 Nov; 46(11):2332-5. PubMed ID: 2866740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]